GREAT POINT PARTNERS LLC Quant / Systematic

Location: Greenwich, CT

CIK: 0001281446 · Show all filings

Period: Q3 2020 (← Previous) (Next →)

Filing Date: Nov 16, 2020

Total Value: $1.112B (100.0% shares, 0.0% debt)

Holdings (34)

IOVA IOVANCE BIOTHERAPEUTICS INC 11.5%
Value $128M Shares 3,876,600 Est. Cost $18.64 Unrealized +64.5%
SAGE THERAPEUTICS INC 10.8%
Value $120M Shares 1,966,688 Est. Cost $46.88 Unrealized
ACAD ACADIA PHARMACEUTICALS INC 7.1%
Value $79.26M Shares 1,921,563 Est. Cost $30.25 Unrealized +42.7%
ARENA PHARMACEUTICALS INC 6.7%
Value $74.56M Shares 996,898 Est. Cost $56.72 Unrealized
ZYMEWORKS INC 6.6%
Value $73.03M Shares 1,567,900 Est. Cost $8101.10 Unrealized
UTHR UNITED THERAPEUTICS CORP DEL 5.8%
Value $64.72M Shares 640,773 Est. Cost $85.83 Unrealized +27.8%
CONSTELLATION PHARMCETICLS I 5.2%
Value $57.98M Shares 2,861,924 Est. Cost $35.95 Unrealized
CYTK CYTOKINETICS INC 5.0%
Value $55.2M Shares 2,549,525 Est. Cost $18.91 Unrealized +23.7%
GW PHARMACEUTICALS PLC 4.6%
Value $50.65M Shares 520,232 Est. Cost $93.52 Unrealized
TGTX TG THERAPEUTICS INC 3.9%
Value $42.82M Shares 1,600,000 Est. Cost $9.56 Unrealized +140.7%
MGNX MACROGENICS INC 3.4%
Value $38.04M Shares 1,510,215 Est. Cost $17.37 Unrealized +57.2%
AUPH AURINIA PHARMACEUTICALS INC 3.3%
Value $36.61M Shares 2,485,327 Est. Cost $14.49 Unrealized 0.0%
GLOBAL BLOOD THERAPEUTICS IN 3.3%
Value $36.15M Shares 655,676 Est. Cost $61.75 Unrealized
BIOHAVEN PHARMACTL HLDG CO L 2.5%
Value $28.28M Shares 435,000 Est. Cost $46.07 Unrealized
VCEL VERICEL CORP 2.5%
Value $27.44M Shares 1,480,787 Est. Cost $13.53 Unrealized +22.3%
GKOS GLAUKOS CORP 2.0%
Value $22.09M Shares 446,097 Est. Cost $37.23 Unrealized +18.0%
GERN GERON CORP 1.5%
Value $16.85M Shares 9,685,528 Est. Cost $1.49 Unrealized +23.7%
PRTA PROTHENA CORP PLC 1.4%
Value $15.47M Shares 1,548,479 Est. Cost $10.02 Unrealized +20.1%
SGMO SANGAMO THERAPEUTICS INC 1.4%
Value $15.02M Shares 1,589,724 Est. Cost $8.53 Unrealized +26.8%
CHEMOCENTRYX INC 1.2%
Value $13.88M Shares 253,230 Est. Cost $54.80 Unrealized
TRANSLATE BIO INC 1.2%
Value $12.84M Shares 943,339 Est. Cost $13.61 Unrealized
ALLO ALLOGENE THERAPEUTICS INC 1.1%
Value $12.4M Shares 328,817 Est. Cost $37.70 Unrealized 0.0%
INTERSECT ENT INC 1.1%
Value $12.2M Shares 747,926 Est. Cost $16.31 Unrealized
IVA INVENTIVA SA 1.1%
Value $11.81M Shares 999,422 Est. Cost $11.82 Unrealized
PBYI PUMA BIOTECHNOLOGY INC 1.0%
Value $11.12M Shares 1,102,073 Est. Cost $10.20 Unrealized -0.1%
CALITHERA BIOSCIENCES INC 0.9%
Value $10.07M Shares 2,918,581 Est. Cost $4.87 Unrealized
KADMON HLDGS INC 0.9%
Value $9.8M Shares 2,500,000 Est. Cost $4.24 Unrealized
VRAYQ VIEWRAY INC 0.8%
Value $9.295M Shares 2,655,763 Est. Cost $3.08 Unrealized -9.6%
LNTH LANTHEUS HLDGS INC 0.7%
Value $7.535M Shares 594,750 Est. Cost $13.71 Unrealized 0.0%
LQDA LIQUIDIA TECHNOLOGIES INC 0.5%
Value $5.853M Shares 1,189,607 Est. Cost $4.01 Unrealized +44.2%
CYTK CYTOKINETICS INC 0.5%
Value $5.477M Shares 253,000 Est. Cost $18.91 Unrealized +23.7%
ABEONA THERAPEUTICS INC 0.4%
Value $3.971M Shares 3,892,921 Est. Cost $2.82 Unrealized
MILLENDO THERAPEUTICS INC 0.2%
Value $1.92M Shares 1,177,900 Est. Cost $7.64 Unrealized
OYSTER PT PHARMA INC 0.1%
Value $1.48M Shares 70,121 Est. Cost $28.88 Unrealized